A phase 1, single blind, placebo-controlled, randomized study to assess the safety of DS-1040b in subjects with thombectomy-treated acute ischemic stroke.
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2017
At a glance
- Drugs DS 1040 (Primary)
- Indications Stroke
- Focus Adverse reactions
- Sponsors Daiichi Sankyo Company
- 01 Aug 2017 Status changed from not yet recruiting to recruiting.
- 14 Jun 2017 New trial record